Mahmoud Laymon

672 total citations
44 papers, 428 citations indexed

About

Mahmoud Laymon is a scholar working on Urology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Mahmoud Laymon has authored 44 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Urology, 24 papers in Pulmonary and Respiratory Medicine and 13 papers in Surgery. Recurrent topics in Mahmoud Laymon's work include Urinary Bladder and Prostate Research (19 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Bladder and Urothelial Cancer Treatments (11 papers). Mahmoud Laymon is often cited by papers focused on Urinary Bladder and Prostate Research (19 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Bladder and Urothelial Cancer Treatments (11 papers). Mahmoud Laymon collaborates with scholars based in Egypt, Qatar and United States. Mahmoud Laymon's co-authors include Ahmed R. El‐Nahas, Ahmed M. Elshal, Ahmed M. Elshal, Ahmed El‐Assmy, Nasr El‐Tabey, Ahmed Mosbah, Hassan Abol‐Enein, Mohamed A. Soltan, Adel Nabeeh and ‬Ahmed M. Harraz and has published in prestigious journals such as The Journal of Urology, Urology and British Journal of Urology.

In The Last Decade

Mahmoud Laymon

39 papers receiving 422 citations

Peers

Mahmoud Laymon
Mahmoud Laymon
Citations per year, relative to Mahmoud Laymon Mahmoud Laymon (= 1×) peers Ahmed M. Elshal

Countries citing papers authored by Mahmoud Laymon

Since Specialization
Citations

This map shows the geographic impact of Mahmoud Laymon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahmoud Laymon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahmoud Laymon more than expected).

Fields of papers citing papers by Mahmoud Laymon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahmoud Laymon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahmoud Laymon. The network helps show where Mahmoud Laymon may publish in the future.

Co-authorship network of co-authors of Mahmoud Laymon

This figure shows the co-authorship network connecting the top 25 collaborators of Mahmoud Laymon. A scholar is included among the top collaborators of Mahmoud Laymon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahmoud Laymon. Mahmoud Laymon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mansour, Islam, Mahmoud Laymon, Ahmed Abdelhalim, Mohamed Dawaba, & Ahmed S. El‐Hefnawy. (2025). Efficacy and Safety of Mirabegron Compared to Solifenacin in Treatment of Non-neurogenic Overactive Bladder in Children: A Randomized Controlled Trial. International braz j urol. 51(2). 1 indexed citations
3.
Ali‐El‐Dein, Bedeir, et al.. (2024). Bladder cancer associated with elevated heavy metals: Investigation of probable carcinogenic pathways through mitochondrial dysfunction, oxidative stress and mitogen-activated protein kinase. Urologic Oncology Seminars and Original Investigations. 43(3). 190.e11–190.e20. 2 indexed citations
5.
Laymon, Mahmoud, et al.. (2023). Randomized trial to assess the potential role of ascorbic acid and statin for post-contrast acute kidney injury prevention. International Urology and Nephrology. 56(2). 399–405.
6.
Laymon, Mahmoud, et al.. (2023). Can we offer additional BCG therapy for three-month BCG refractory high grade/T1, Tis bladder cancer patients?. Arab Journal of Urology. 21(3). 142–149. 2 indexed citations
7.
El‐Assmy, Ahmed, et al.. (2022). A randomized trial of adjuvant tamsulosin as a medical expulsive therapy for renal stones after shock wave lithotripsy. Urolithiasis. 50(4). 473–480. 1 indexed citations
8.
Awadalla, Amira, ‬Ahmed M. Harraz, Hassan Abol‐Enein, et al.. (2021). Prognostic influence of microsatellite alterations of muscle-invasive bladder cancer treated with radical cystectomy. Urologic Oncology Seminars and Original Investigations. 40(2). 64.e9–64.e15. 3 indexed citations
9.
Laymon, Mahmoud, et al.. (2021). Oncologic Outcomes of Squamous Cell Carcinoma Versus Urothelial Carcinoma With Squamous Differentiation After Radical Cystectomy for Bladder Carcinoma. Clinical Genitourinary Cancer. 20(2). 148–154. 3 indexed citations
10.
Harraz, ‬Ahmed M., et al.. (2021). Development and validation of a simple stone score to estimate the probability of residual stones prior to percutaneous nephrolithotomy. Minerva Urology and Nephrology. 73(4). 4 indexed citations
12.
El‐Nahas, Ahmed R., et al.. (2020). Preoperative risk factors for complications of percutaneous nephrolithotomy. Urolithiasis. 49(2). 153–160. 19 indexed citations
15.
Elshal, Ahmed M., et al.. (2018). Low-Power Vs High-Power Holmium Laser Enucleation of the Prostate: Critical Assessment through Randomized Trial. Urology. 121. 58–65. 33 indexed citations
16.
Elshal, Ahmed M., et al.. (2017). Prospective controlled assessment of men’s sexual function changes following Holmium laser enucleation of the prostate for treatment of benign prostate hyperplasia. International Urology and Nephrology. 49(10). 1741–1749. 22 indexed citations
19.
Elshal, Ahmed M., et al.. (2015). Towards optimizing prostate tissue retrieval following holmium laser enucleation of the prostate (HoLEP): Assessment of two morcellators and review of literature. Canadian Urological Association Journal. 9(9-10). 618–618. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026